or Try an Advanced Search...

    ETF Components for XPH - SPDR S&P Pharmaceuticals ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    MRK A 0.27 4.81
    PRGO B 0.97 4.79
    CTLT D -0.07 4.74
    ITCI A -0.84 4.74
    LLY D -1.76 4.69
    OGN B -0.38 4.66
    AXSM D -3.90 4.57
    PFE F -0.09 4.56
    JAZZ F -1.54 4.55
    RPRX F 0.14 4.50
    VTRS C 0.97 4.44
    JNJ F -0.72 4.39
    BMY F -0.04 4.30
    ELAN D -0.78 4.22
    ZTS F 0.96 4.21
    CORT F -2.61 3.44
    ARVN D -3.66 2.80
    EYPT D -6.83 2.57
    SAVA D 0.56 2.42
    AMPH D 0.48 2.02
    TARS B -2.34 1.94
    PBH B -2.02 1.38
    PCRX F -3.39 1.24
    HRMY F 1.11 1.21
    LBPH B -1.33 1.21
    LQDA D -2.78 1.17
    COLL C -1.39 1.09
    INVA B 0.10 1.00
    SUPN D 0.90 0.93
    LGND B 0.65 0.89
    AMRX D 11.83 0.80
    RVNC F -2.73 0.71
    PLRX F -4.95 0.67
    ANIP A -0.44 0.64
    OCUL D -6.00 0.60
    EOLS D -1.88 0.49
    XERS F -1.12 0.40
    TBPH B -0.33 0.36
    MRNS F -2.43 0.35
    FULC D -2.15 0.29

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Pain Pharmaceutical Medicine Pharmaceutical Products S&P 500 Alzheimer's Disease Animal Health Drugs Neuroscience Biotechnology Depression Diabetes Disease Hypertension Life Sciences Medication Pharmacology Suspension Antibiotics
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution

    Recent News for SPDR S&P Pharmaceuticals ETF & its Holdings

    Date Stock Title
    Apr 24 LLY Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
    Apr 24 MRK 4 Large Drug Stocks to Hold on to Amid Industry Challenges
    Apr 24 LLY 4 Large Drug Stocks to Hold on to Amid Industry Challenges
    Apr 24 MRK Merck Q1 Earnings Preview: Strong quarter expectations on the back of core products' growth
    Apr 24 LLY Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
    Apr 24 BMY Bristol-Myers Earnings Preview: Major near-term headwinds invites worries about Q1 results
    Apr 24 LLY Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
    Apr 24 BMY What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
    Apr 24 JNJ The Zacks Analyst Blog Highlights KB Home, Interactive Brokers Group, Qualcomm and Johnson & Johnson
    Apr 24 OCUL 2 Small-Cap Growth Stocks With Room to Run
    Apr 24 INVA Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
    Apr 24 LLY Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
    Apr 24 LQDA When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable?
    Apr 24 JNJ These Are the 10 High-Profile Stocks U.S. Politicians Have Gravitated to Most Over the Last 3 Years
    Apr 24 JNJ Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
    Apr 24 JAZZ 3 No-Brainer Stocks to Buy With $300 Right Now
    Apr 24 JNJ 14 Dividend Growth Stocks with Highest Growth Rates
    Apr 24 LLY 14 Dividend Growth Stocks with Highest Growth Rates
    Apr 24 ZTS 14 Dividend Growth Stocks with Highest Growth Rates
    Apr 23 EOLS Evolus to Report First Quarter Financial Results on May 7, 2024
    The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund S&P Top 100 Loan Index Pharmaceuticals Segment
    Back to the Main XPH Page...